🔴 Cerenome is trading 5.3% down today amid broader market weakness and rate uncertainty

Cerenome is trading 5.3% down at $2.20, with broader market weakness and elevated rate uncertainty the most likely context.

• The price declined from $2.33 on September 11, continuing a seven-day slide.
• No new company-specific announcement or clearly reported catalyst was found for September 14, 2026.
• A September 4 filing disclosed convertible-note financing totaling up to $21.28 million, but available sources do not explicitly link it to today’s move.